-
1
المؤلفون: AK Nooka, LJ Costa, CJ Gasparetto, PG Richardson, DS Siegel, A Chari, S Lentzsch, S Jagannath, J. Mikhael
المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:e526-e531
مصطلحات موضوعية: Adult, Cancer Research, Consensus, Hydrazines, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Hematology, Triazoles, Multiple Myeloma, Dexamethasone
-
2
المصدر: Value in Health. 25:S346
مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health
-
3
المؤلفون: Rammurti T. Kamble, Carla S. Wilson, DS Siegel, B. Barlogie, E Anaissie, G Tricot, P Anderson, A. Fassas, R Desikan, JR Sawyer
المصدر: Leukemia & Lymphoma. 46:1137-1142
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Pathology, Pleural effusion, Diagnosis, Differential, Predictive Value of Tests, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Malignant pleural effusion, Multiple myeloma, Aged, L-Lactate Dehydrogenase, business.industry, Cytogenetics, Hematology, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Pleural Effusion, Malignant, Lymphoma, Leukemia, C-Reactive Protein, Treatment Outcome, Oncology, Karyotyping, Plasmacytoma, Female, Multiple Myeloma, beta 2-Microglobulin, business, Follow-Up Studies
-
4
المصدر: Clinical Lymphoma and Myeloma. 9:S41
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, Internal medicine, medicine, business, Vorinostat, Dexamethasone, Lenalidomide, medicine.drug
-
5دورية أكاديمية
المؤلفون: Siegel DS; Gilead Sciences, Inc., Foster City, California 94404, United States., Hui HC; Gilead Sciences, Inc., Foster City, California 94404, United States., Pitts J; Gilead Sciences, Inc., Foster City, California 94404, United States., Vermillion MS; Gilead Sciences, Inc., Foster City, California 94404, United States.; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Ishida K; Gilead Sciences, Inc., Foster City, California 94404, United States., Rautiola D; Gilead Sciences, Inc., Foster City, California 94404, United States., Keeney M; Gilead Sciences, Inc., Foster City, California 94404, United States., Irshad H; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Zhang L; Gilead Sciences, Inc., Foster City, California 94404, United States., Chun K; Gilead Sciences, Inc., Foster City, California 94404, United States., Chin G; Gilead Sciences, Inc., Foster City, California 94404, United States., Goyal B; Gilead Sciences, Inc., Foster City, California 94404, United States., Doerffler E; Gilead Sciences, Inc., Foster City, California 94404, United States., Yang H; Gilead Sciences, Inc., Foster City, California 94404, United States., Clarke MO; Gilead Sciences, Inc., Foster City, California 94404, United States., Palmiotti C; Gilead Sciences, Inc., Foster City, California 94404, United States., Vijjapurapu A; Gilead Sciences, Inc., Foster City, California 94404, United States., Riola NC; Gilead Sciences, Inc., Foster City, California 94404, United States., Stray K; Gilead Sciences, Inc., Foster City, California 94404, United States., Murakami E; Gilead Sciences, Inc., Foster City, California 94404, United States., Ma B; Gilead Sciences, Inc., Foster City, California 94404, United States., Wang T; Gilead Sciences, Inc., Foster City, California 94404, United States., Zhao X; Gilead Sciences, Inc., Foster City, California 94404, United States., Xu Y; Gilead Sciences, Inc., Foster City, California 94404, United States., Lee G; Gilead Sciences, Inc., Foster City, California 94404, United States., Marchand B; Gilead Sciences, Inc., Foster City, California 94404, United States., Seung M; Gilead Sciences, Inc., Foster City, California 94404, United States., Nayak A; Gilead Sciences, Inc., Foster City, California 94404, United States., Tomkinson A; Gilead Sciences, Inc., Foster City, California 94404, United States., Kadrichu N; Inspired - Pulmonary Solutions, San Carlos, California 94070, United States., Ellis S; Gilead Sciences, Inc., Foster City, California 94404, United States., Barauskas O; Gilead Sciences, Inc., Foster City, California 94404, United States., Feng JY; Gilead Sciences, Inc., Foster City, California 94404, United States., Perry JK; Gilead Sciences, Inc., Foster City, California 94404, United States., Perron M; Gilead Sciences, Inc., Foster City, California 94404, United States., Bilello JP; Gilead Sciences, Inc., Foster City, California 94404, United States., Kuehl PJ; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Subramanian R; Gilead Sciences, Inc., Foster City, California 94404, United States., Cihlar T; Gilead Sciences, Inc., Foster City, California 94404, United States., Mackman RL; Gilead Sciences, Inc., Foster City, California 94404, United States.
المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Jul 17. Date of Electronic Publication: 2024 Jul 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
-
6دورية أكاديمية
المؤلفون: Gordon CJ; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Walker SM; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Tchesnokov EP; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Kocincova D; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Pitts J; Gilead Sciences, Inc., Foster City, California, USA., Siegel DS; Gilead Sciences, Inc., Foster City, California, USA., Perry JK; Gilead Sciences, Inc., Foster City, California, USA., Feng JY; Gilead Sciences, Inc., Foster City, California, USA., Bilello JP; Gilead Sciences, Inc., Foster City, California, USA., Götte M; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada. Electronic address: gotte@ualberta.ca.
المصدر: The Journal of biological chemistry [J Biol Chem] 2024 Jun 28, pp. 107514. Date of Electronic Publication: 2024 Jun 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: Pinion AK; Department of Ecology and Conservation Biology and Biodiversity Research and Teaching Collections, Texas A&M University, College Station, Texas, USA., Britz R; Senckenberg Naturhistorische Sammlungen Dresden, Dresden, Germany., Kubicek KM; Department of Biology, Lamar University, Beaumont, Texas, USA., Siegel DS; Department of Biology, Southeast Missouri State University, Cape Girardeau, Missouri, USA., Conway KW; Department of Ecology and Conservation Biology and Biodiversity Research and Teaching Collections, Texas A&M University, College Station, Texas, USA.
المصدر: Journal of fish biology [J Fish Biol] 2023 Dec; Vol. 103 (6), pp. 1300-1311. Date of Electronic Publication: 2023 Sep 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 0214055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8649 (Electronic) Linking ISSN: 00221112 NLM ISO Abbreviation: J Fish Biol Subsets: MEDLINE
مواضيع طبية MeSH: Fishes*, Animals ; Larva ; Phylogeny ; Microscopy, Electron, Scanning
-
8دورية أكاديمية
المؤلفون: Lin Y; Mayo Clinic, Rochester, MN, USA. lin.yi@mayo.edu., Raje NS; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Berdeja JG; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA., Siegel DS; Hackensack University Medical Center, Hackensack, NJ, USA., Jagannath S; Mount Sinai Medical Center, New York City, NY, USA., Madduri D; Mount Sinai Medical Center, New York City, NY, USA., Liedtke M; Stanford University Medical Center, Palo Alto, CA, USA., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA, USA., Maus MV; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Massaro M; 2SeventyBio, Inc, Cambridge, MA, USA., Petrocca F; 2SeventyBio, Inc, Cambridge, MA, USA., Yeri A; 2SeventyBio, Inc, Cambridge, MA, USA., Finney O; 2SeventyBio, Inc, Cambridge, MA, USA., Caia A; Bristol Myers Squibb, Princeton, NJ, USA., Yang Z; Bristol Myers Squibb, Princeton, NJ, USA., Martin N; Bristol Myers Squibb, Princeton, NJ, USA., Campbell TB; Bristol Myers Squibb, Princeton, NJ, USA., Rytlewski J; Bristol Myers Squibb, Princeton, NJ, USA., Fuller J; Bristol Myers Squibb, Princeton, NJ, USA., Hege K; Bristol Myers Squibb, Princeton, NJ, USA., Munshi NC; Dana-Farber Cancer Institute, Boston, MA, USA., Kochenderfer JN; Surgery Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD, USA.
المصدر: Nature medicine [Nat Med] 2023 Sep; Vol. 29 (9), pp. 2286-2294. Date of Electronic Publication: 2023 Aug 17.
نوع المنشور: Multicenter Study; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/therapy , Receptors, Chimeric Antigen*, Humans ; B-Cell Maturation Antigen ; Follow-Up Studies ; Cytokine Release Syndrome
-
9دورية أكاديمية
المؤلفون: Bariana M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey., Cassella E; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey., Rateshwar J; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey., Ouk S; ImmuneTarget Inc., San Diego, California., Liou HC; ImmuneTarget Inc., San Diego, California., Heller C; Hackensack Meridian School of Medicine, Nutley, New Jersey., Colorado I; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey., Feinman R; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey., Makhdoom A; Hackensack Meridian School of Medicine, Nutley, New Jersey., Siegel DS; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.; Multiple Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Heller G; Memorial Sloan Kettering Cancer Center, New York, New York., Tuckett A; Memorial Sloan Kettering Cancer Center, New York, New York., Mondello P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Zakrzewski JL; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.; Department of Oncology, Georgetown University, Washington, DC.; Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Dec 02; Vol. 21 (12), pp. 1798-1809.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/genetics , Multiple Myeloma*/metabolism, Mice ; Animals ; Humans ; NF-kappa B/metabolism ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Tumor Microenvironment ; Apoptosis ; I-kappa B Proteins/metabolism ; Oxidation-Reduction ; DNA/metabolism ; Cell Line, Tumor
-
10Editorial & Opinion
المؤلفون: Gill SK; Department of Medicine, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA. sarvarinder.gill@hmhn.org., Unawane R; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Wang S; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA., Ahn J; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA., Aleman A; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Siegel DS; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Vesole DH; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Parmar H; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Phull P; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA., Biran N; Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.
المصدر: Blood cancer journal [Blood Cancer J] 2022 Sep 23; Vol. 12 (9), pp. 138. Date of Electronic Publication: 2022 Sep 23.
نوع المنشور: Letter
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Rubiaceae*, Antineoplastic Combined Chemotherapy Protocols ; Dexamethasone/therapeutic use ; Humans